CX Institutional’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Buy |
4,351
+1,232
| +39% | +$187K | 0.02% | 320 |
|
|
2025
Q1 | $469K | Sell |
3,119
-113
| -3% | -$17K | 0.02% | 381 |
|
|
2024
Q4 | $597K | Sell |
3,232
-112
| -3% | -$20.7K | 0.02% | 319 |
|
|
2024
Q3 | $659K | Sell |
3,344
-154
| -4% | -$30.3K | 0.03% | 337 |
|
|
2024
Q2 | $723K | Sell |
3,498
-1
| -0% | -$207 | 0.03% | 322 |
|
|
2024
Q1 | $948K | Buy |
3,499
+20
| +0.6% | +$5.42K | 0.05% | 288 |
|
|
2023
Q4 | $822K | Buy |
3,479
+133
| +4% | +$31.4K | 0.04% | 282 |
|
|
2023
Q3 | $656K | Buy |
3,346
+19
| +0.6% | +$3.72K | 0.04% | 297 |
|
|
2023
Q2 | $700K | Buy |
3,327
+170
| +5% | +$35.7K | 0.04% | 318 |
|
|
2023
Q1 | $632K | Buy |
3,157
+11
| +0.3% | +$2.2K | 0.03% | 331 |
|
|
2022
Q4 | $686K | Buy |
3,146
+38
| +1% | +$8.28K | 0.04% | 324 |
|
|
2022
Q3 | $612K | Buy |
3,108
+5
| +0.2% | +$985 | 0.04% | 316 |
|
|
2022
Q2 | $664K | Sell |
3,103
-7
| -0.2% | -$1.5K | 0.05% | 279 |
|
|
2022
Q1 | $883K | Buy |
3,110
+2
| +0.1% | +$568 | 0.07% | 229 |
|
|
2021
Q4 | $1.17M | Buy |
3,108
+2
| +0.1% | +$754 | 0.09% | 190 |
|
|
2021
Q3 | $1.28M | Sell |
3,106
-2
| -0.1% | -$825 | 0.1% | 192 |
|
|
2021
Q2 | $1.15M | Hold |
3,108
| – | – | 0.09% | 197 |
|
|
2021
Q1 | $901K | Hold |
3,108
| – | – | 0.08% | 201 |
|
|
2020
Q4 | $777K | Hold |
3,108
| – | – | 0.07% | 213 |
|
|
2020
Q3 | $704K | Buy |
3,108
+1
| +0% | +$227 | 0.08% | 189 |
|
|
2020
Q2 | $542K | Buy |
3,107
+7
| +0.2% | +$1.22K | 0.07% | 187 |
|
|
2020
Q1 | $391K | Hold |
3,100
| – | – | 0.06% | 191 |
|
|
2019
Q4 | $474K | Hold |
3,100
| – | – | 0.08% | 152 |
|
|
2019
Q3 | $410K | Sell |
3,100
-14
| -0.4% | -$1.85K | 0.07% | 173 |
|
|
2019
Q2 | $442K | Buy |
3,114
+14
| +0.5% | +$1.99K | 0.07% | 166 |
|
|
2019
Q1 | $450K | Hold |
3,100
| – | – | 0.08% | 162 |
|
|
2018
Q4 | $351K | Buy |
+3,100
| New | +$351K | 0.07% | 145 |
|